BroadSpot Imaging Corporation is a pioneering company in the field of eye care, offering advanced imaging technology and compact, cloud-connected devices. Established in 2013, the company's mission is to revolutionize the diagnostic tools for eye care by replacing bulky and expensive devices with affordable handheld instruments and valuable services. The innovations introduced by BroadSpot Imaging Corporation are poised to enhance the global delivery of eye care, allowing for more efficient and cost-effective treatment, especially as the aging population increases.
The company's recent milestone includes a $8.60M Series A investment received on October 9, 2018. The investment was made by a consortium of prominent venture capital firms including BlueStone Venture Partners, Phoenix Venture Partners, Burwell Investments, and Camino Real Capital Partners.
BroadSpot Imaging Corporation operates within the biotechnology, fashion, health care, and medical devices industries, reflecting its multi-faceted approach to innovation. With its commitment to affordability, efficiency, and accessibility in eye care, the company is strategically positioned to capitalize on the growing demand for advanced diagnostic solutions.
